HomeProductsBuilding BlocksHeterocyclic ScaffoldsMorpholinesReboxetine
Chemical structure of CAS 71620-89-8

Reboxetine

In Stock•Starting at $311 for 100 mg•Purity ≥ 98%
CAS No.71620-89-8
MDL No.MFCD09955493
MFC19H23NO3
MW313.40
InChI KeyCBQGYUDMJHNJBX-RTBURBONSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
100 mg98%;RG$311In Stock
500 mg98%;RG$797In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Reboxetine is an aromatic ether.

CAS No.71620-89-8
Product NameReboxetine
Heavy Atom Count23Rotatable Bond Count6
Atom Stereo Count2Bond Stereo Count0
HBA4HBD1
TPSA39.720 ŲCharge0
Exact Mass313.16779Complexity596.57
pKa2.025XLogP3.194

Related Articles

Studies related to this compound and its mechanism of action

Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex.

British journal of pharmacology • Vol. 132, Issue 1 • 2001
PMID: 11156576PMC: PMC1572559DOI: 10.1038/sj.bjp.0703821

Effect of reboxetine treatment on brain cAMP- and calcium/calmodulin-dependent protein kinases.

Neuropharmacology • Vol. 40, Issue 3 • 2001
PMID: 11166338DOI: 10.1016/s0028-3908(00)00164-7

Bioanalysis of racemic reboxetine and its desethylated metabolite in a therapeutic drug monitoring setting using solid phase extraction and HPLC.

Therapeutic drug monitoring • Vol. 23, Issue 1 • 2001
PMID: 11206039DOI: 10.1097/00007691-200102000-00006

Role of serotonin and noradrenaline in social dysfunction: a review of data on reboxetine and the Social Adaptation Self-evaluation Scale (SASS).

General hospital psychiatry • Vol. 23, Issue 1 • 2001
PMID: 11226552DOI: 10.1016/s0163-8343(00)00115-8

Documentation

Similar Products